BamSEC and AlphaSense Join Forces
Learn More

Brainstorm Cell Therapeutics Inc. – Material Contracts

OTC: BCLI    
Share price (8/21/26): $0.98    
Market cap (8/21/26): $10.8 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.9
from 10-Q 14 pages The Issue Price of This Note Is $151,800.00 the Original Issue Discount Is $19,800.00
12/34/56
EX-10.6
from 10-Q 14 pages The Issue Price of This Note Is $151,800.00 the Original Issue Discount Is $19,800.00
12/34/56
EX-10.5
from 10-Q 15 pages Promissory Note
12/34/56
EX-10.5
from 8-K 4 pages Consulting Agreement
12/34/56
EX-10.4
from 8-K 10 pages Brainstorm Cell Therapeutics Inc. 2014 Global Share Option Plan Restricted Stock Unit Grant Notice
12/34/56
EX-10.3
from 8-K 3 pages Consulting Agreement
12/34/56
EX-10.2
from 8-K 11 pages Brainstorm Cell Therapeutic Inc. 2014 Stock Incentive Plan Stock Option Grant Notice
12/34/56
EX-10.1
from 8-K 4 pages On Behalf of Brainstorm Cell Therapeutics Inc. (The “Company”), I Am Pleased to Provide You With This Letter Agreement (This “Agreement”) Setting Forth the Terms and Conditions of Your Employment as Executive Chairman and Chief Strategic Regulatory Officer (“Chairman”) of the Company, Effective as of July 24, 2026 (The “Effective Date”). 1. Term. the Company Will Employ You as Chairman, Upon the Terms and Subject to the Conditions Set Forth in This Agreement, Beginning on the Effective Date and Ending When Your Employment Terminates Pursuant to Paragraph 9 (The “Term”)
12/34/56
EX-10.1
from 8-K 18 pages Brainstorm Cell Therapeutics Inc. Indemnification Agreement
12/34/56
EX-10.107
from S-1 39 pages Securities Purchase Agreement
12/34/56
EX-10.4
from 10-Q 22 pages Common Stock Purchase Warrant Brainstorm Cell Therapeutics Inc
12/34/56
EX-10.3
from 10-Q 39 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 10-Q 14 pages The Issue Price of This Note Is $151,800.00 the Original Issue Discount Is $19,800.00
12/34/56
EX-10.1
from 10-Q 12 pages Securities Purchase Agreement
12/34/56
EX-10.15
from 8-K 1 page Brainstorm Cell Therapeutics Inc. Amendment No. 6 to 2014 Global Share Option Plan
12/34/56
EX-10.8
from 8-K 1 page Brainstorm Cell Therapeutics Inc. Amendment No. 6 to 2014 Stock Incentive Plan
12/34/56
EX-10.1
from 8-K 43 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 42 pages Securities Purchase Agreement
12/34/56
EX-10.6
from 8-K 19 pages Promissory Note
12/34/56
EX-10.5
from 8-K 29 pages Securities Purchase Agreement
12/34/56